Research Suggests Some Premature Infants May Go Home From the NICU Up To Three Weeks Earlier When Fed Prolacta’s 100% Human Milk-Based Nutritional Products; Those with Bronchopulmonary Dysplasia May Benefit the Most
30 juil. 2020 09h05 HE
|
Prolacta Bioscience
DUARTE, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- A retrospective study indicates that premature infants’ stays in neonatal intensive care units (NICUs) are reduced anywhere from 4.5 to 22.9 days...
Multiple NICUs Showed Improved Growth & Lung Health in Premature Infants by Fortifying Feeds Safely in the First Days of Life with Prolacta’s 100% Human Milk-Based Fortifiers
14 juil. 2020 09h05 HE
|
Prolacta Bioscience
DUARTE, Calif., July 14, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today the results of an...
Preterm Infants Fed Prolacta’s 100% Human Milk-Based Fortifiers Achieved Catch-Up Growth by Age 2 with Appropriate Neurodevelopmental Outcomes, Study Says
01 juin 2020 09h05 HE
|
Prolacta Bioscience
DUARTE, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today the results of a...
Head-to-Head Subgroup Analysis of Human Milk–Based Fortifiers Finds Significant Improvements in Health and Brain Growth Measure for Preemies Fed Mother’s Milk Plus Prolacta’s Fortifiers
12 mai 2020 09h05 HE
|
Prolacta Bioscience
DUARTE, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk–based nutritional products, announced today that a subgroup analysis...
UPDATE - Prolacta Bioscience Reassures Hospitals of the Safety of Its Human Milk-Based Nutritional Products During the Coronavirus Pandemic
02 avr. 2020 23h55 HE
|
Prolacta Bioscience
DUARTE, Calif., April 02, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience,® the world’s leading hospital provider of 100% human milk-based nutritional products, today notified hospital customers of the...
Prolacta Bioscience Reassures Hospitals of the Safety of Its Human Milk-Based Nutritional Products During the Coronavirus Pandemic
02 avr. 2020 15h50 HE
|
Prolacta Bioscience
DUARTE, Calif., April 02, 2020 (GLOBE NEWSWIRE) -- Prolacta Bioscience®, the world’s leading hospital provider of 100% human milk-based nutritional products, today notified hospital customers of the...
Therapeutic Respiratory Devices Market worth over $21.5 billion by 2024: Global Market Insights, Inc.
28 juin 2018 06h00 HE
|
Global Market Insights, Inc
Sellbyville, Delaware, June 28, 2018 (GLOBE NEWSWIRE) -- Global Therapeutic Respiratory Devices Market is poised to exceed USD 21.5 billion by 2024; according to a new research report by Global...
Innara Health Announces Co-Marketing Agreement with GE Healthcare to Advance Oral Feeding and Neurodevelopment of Premature Infants
21 mars 2017 08h09 HE
|
Innara Health
Olathe, March 21, 2017 (GLOBE NEWSWIRE) -- Contact Wendy SlateryFOR IMMEDIATE RELEASETelephone 608-213-1449 E-mail wslatery@innarahealth.com Innara Health Announces Co-Marketing Agreement with...
NTrainer System® Shown to Help Neonatal Feeding Readiness Skills
01 mars 2016 09h35 HE
|
Innara Health
OLATHE, Kan., March 01, 2016 (GLOBE NEWSWIRE) -- Innara Health today announced that a multi-center randomized control trial (RCT) has shown that premature infants who received treatment with the...
Connecticut Children's Medical Center Hires New Neonatal Intensive Care Unit Chief
06 févr. 2015 11h59 HE
|
Connecticut Childrens Medical Center
HARTFORD, Conn., Feb. 6, 2015 (GLOBE NEWSWIRE) -- Connecticut Children's Medical Center is pleased to announce the appointment of James E. Moore. M.D., Ph.D., to Chief of the Neonatal Intensive Care...